(HealthDay)—Pediatric patients with nasopharyngeal carcinoma (NPC) are more often black and present with stage IV disease, but they have lower mortality than adult patients, according to a study published online Jan. 14 ...
Jan 23, 2016
0
3
(HealthDay)—Pretreatment neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be predictors for survival in nasopharyngeal carcinoma, according to a study published online Sept. 11 in Head & Neck.
Sep 22, 2015
0
7
(HealthDay)—Excision repair cross-complementing group 1 (ERCC1) genotype for the single nucleotide polymorphism (SNP) cytosine-to-thymine substitution at codon 118 (C118T) interacts with post-radiotherapy plasma Epstein-Barr ...
Aug 27, 2015
0
20
Researchers at the University of Birmingham believe that a new method of genetically engineering immune cells could lead to improved treatment of Nasopharyngeal carcinoma (NPC) patients.
Mar 10, 2015
0
5
(HealthDay)—Patients with allergic rhinitis may have an increased risk of developing nasopharyngeal carcinoma (NPC), according to a Taiwanese study published in the March issue of Head & Neck.
Feb 24, 2015
0
5
A team of scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore, National University Cancer Institute Singapore (NCIS) and National University Hospital Singapore ...
Jun 23, 2014
0
0
Nasopharyngeal carcinoma (NPC) affects cells lining the nasopharynx. The majority of NPC cases can be cured by radiation therapy, however ~20% are resistant to radiation treatment.
Nov 25, 2013
0
0
Survivors of nasopharyngeal carcinoma who are former or current smokers are more likely to have their disease progress, relapse, or spread, and are more likely to die of their disease, compared with survivors of nasopharyngeal ...
Nov 19, 2013
0
0
Development of a vaccine against Epstein-Barr virus (EBV) has taken a step forward with the Canadian discovery of how EBV infection evades detection by the immune system.
Oct 11, 2013
0
0
Epstein-Barr virus (EBV) affects more than 90 percent of the population worldwide and was the first human virus found to be associated with cancer. Now, researchers from Beth Israel Deaconess Medical Center (BIDMC) have broadened ...
Feb 21, 2013
0
0
